Lucie Ahn

567 total citations
10 papers, 388 citations indexed

About

Lucie Ahn is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Lucie Ahn has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Biomaterials. Recurrent topics in Lucie Ahn's work include Nanoparticle-Based Drug Delivery (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Lucie Ahn is often cited by papers focused on Nanoparticle-Based Drug Delivery (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Lucie Ahn collaborates with scholars based in United States, Türkiye and Brazil. Lucie Ahn's co-authors include Kris C. Wood, Grace R. Anderson, Christina Chao, Merve Çakır, Suzanne E. Wardell, Xinghai Li, Minshu Yu, Parisa Yousefpour, Donald P. McDonnell and Ashutosh Chilkoti and has published in prestigious journals such as Cell, Nature Communications and Nature Genetics.

In The Last Decade

Lucie Ahn

10 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucie Ahn United States 7 286 94 91 55 36 10 388
Xuan Qin China 12 354 1.2× 128 1.4× 60 0.7× 22 0.4× 26 0.7× 25 481
Xuesai Zhang China 10 214 0.7× 147 1.6× 62 0.7× 56 1.0× 16 0.4× 13 421
Sylvie Avril France 12 266 0.9× 193 2.1× 105 1.2× 59 1.1× 17 0.5× 14 492
Shane W. O’Brien United States 12 401 1.4× 188 2.0× 88 1.0× 26 0.5× 59 1.6× 14 602
Nobuhide Ueki United States 13 394 1.4× 119 1.3× 67 0.7× 23 0.4× 38 1.1× 19 501
Timothy A. Yap United Kingdom 8 289 1.0× 200 2.1× 111 1.2× 44 0.8× 14 0.4× 10 568
Christine Mantis United States 6 257 0.9× 64 0.7× 38 0.4× 46 0.8× 32 0.9× 12 360
Joseph Wynne United States 8 262 0.9× 83 0.9× 98 1.1× 16 0.3× 48 1.3× 13 493
Kenichiro Naito Japan 6 296 1.0× 96 1.0× 129 1.4× 28 0.5× 13 0.4× 14 386
Erkan Yuca United States 11 323 1.1× 188 2.0× 100 1.1× 25 0.5× 20 0.6× 21 492

Countries citing papers authored by Lucie Ahn

Since Specialization
Citations

This map shows the geographic impact of Lucie Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Ahn more than expected).

Fields of papers citing papers by Lucie Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucie Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Ahn. The network helps show where Lucie Ahn may publish in the future.

Co-authorship network of co-authors of Lucie Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Lucie Ahn. A scholar is included among the top collaborators of Lucie Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucie Ahn. Lucie Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Baluapuri, Apoorva, Ning Zhao, Ryan J. Marina, et al.. (2025). Integrator loss leads to dsRNA formation that triggers the integrated stress response. Cell. 188(12). 3184–3201.e21. 5 indexed citations
2.
Wang, Yajuan, et al.. (2024). Pharmacological chaperones restore proteostasis of epilepsy-associated GABAA receptor variants. Pharmacological Research. 208. 107356–107356. 3 indexed citations
3.
Lin, Kevin, Justine C. Rutter, Abigail Xie, et al.. (2020). Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer. Nature Genetics. 52(4). 408–417. 39 indexed citations
4.
Ahn, Lucie, et al.. (2020). An epilepsy‐associated ACTL6B variant captures neuronal hyperexcitability in a human induced pluripotent stem cell model. Journal of Neuroscience Research. 99(1). 110–123. 7 indexed citations
5.
Lin, Kevin, Abigail Xie, Justine C. Rutter, et al.. (2019). Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity. Cell Metabolism. 29(5). 1217–1231.e7. 69 indexed citations
6.
Yousefpour, Parisa, Lucie Ahn, Soumen Saha, et al.. (2019). Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin. Small. 15(12). e1804452–e1804452. 50 indexed citations
7.
Yousefpour, Parisa, Jonathan R. McDaniel, Lucie Ahn, et al.. (2018). Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy. Nano Letters. 18(12). 7784–7793. 41 indexed citations
8.
Anderson, Grace R., Suzanne E. Wardell, Merve Çakır, et al.. (2018). Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors. Nature Communications. 9(1). 1677–1677. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026